leadf
logo-loader
Deep dive

Creso Pharma prepares for dual listing on Nasdaq as it storms ahead into new...

Ahead of favourable regulatory changes in the US, the cannabinoid therapy developer hopes the...

1 day, 11 hours ago
What brokers say

Amryt Pharma impresses broker at Capital Markets Day

"A unique, cash-flow positive, global, commercial-stage company with two growth assets"

2 days, 2 hours ago
Deep dive

Kintara Therapeutics is developing innovative cancer therapies for rare,...

The company has two Phase 3-ready drug development candidates and is well capitalized to achieve...

6 days, 6 hours ago
Deep dive

Mindset Pharma leading the charge to advance psychedelic medicines to treat...

The company is developing intellectual property in two areas it believes are going to be the...

6 days, 23 hours ago

Emmaus Life Sciences progressing with expanding availability of lead drug...

Emmaus Life Sciences Inc CEO Yutaka Niihara joined Proactive to discuss the Torrance, California-based group's focus on expanding its FDA approved drug, Endari, to treat sickle cell disease internationally, specifically focusing in on the Middle East. Niihara says recently, the National...

1 hour, 27 minutes ago

Join Proactive

Get ahead of the curve